Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2015-04-17 | Brian P. Concannon 57 2013 President and Chief Executive Officer of Haemonetics Corporation (NYSE: HAE); Director of the Company. As noted below, the Board of Directors has determined that Mr. Concannon is independent. |
| 2016-04-15 | Brian P. Concannon (age 58) has served as a Director of the Company since July 2013. ... The Board of Directors has determined that Mr. Concannon is independent. |
| 2017-04-13 | Brian P. Concannon 59 2013 Former President and Chief Executive Officer of Haemonetics Corporation (NYSE: HAE); Director of the Company. As noted below, the Board of Directors has determined that Mr. Concannon is independent. ... Compensation Committee members: Dirk M. Kuyper (Chair), Charles M. Farkas, Martha Goldberg Aronson, Jerome J. Lande. ... Corporate Governance and Nominating Committee members: Brian P. Concannon (Chair), David Bronson, Dirk M. Kuyper, Mark E. Tryniski. ... Strategy Committee members: Charles M. Farkas (Chair), Brian P. Concannon, Jerome J. Lande, Mark E. Tryniski. ... Director Compensation Table shows Brian P. Concannon total compensation as $217,465. |
| 2018-04-12 | Brian P. Concannon (age 60) has served as a Director of the Company since July 2013. The Board of Directors has determined that Mr. Concannon is independent. |
| 2019-04-12 | Brian P. Concannon (age 61) has served as a Director of the Company since July 2013. ... The Board of Directors has determined that Mr. Concannon is independent within the meaning of the rules of the Securities and Exchange Commission. ... Corporate Governance and Nominating Committee: Brian P. Concannon (Chair), David Bronson, Martha Goldberg Aronson, Dirk M. Kuyper ... Strategy Committee: Charles M. Farkas (Chair), Brian P. Concannon, Jerome J. Lande ... Director Compensation Table: Brian P. Concannon Fees Earned or Paid in Cash $67,500, Stock Awards $112,450, Option Awards $37,496, Total $217,446. |
| 2020-04-10 | BRIAN P. CONCANNON (age 62) has served as a Director of the Company since July 2013. ... Committees: - Compensation - Strategy ... Director Compensation Table ... Brian P. Concannon ... Fees Earned or Paid in Cash ($) 78,750 ... Stock Awards ($) 112,476 ... Option Awards ($) 37,498 ... Total ($) 228,724 |
| 2021-04-09 | Brian P. Concannon Age 63 Director since 2013 Committees: Compensation, Strategy ... Cash fees paid to directors ... Brian P. Concannon $75,000, Stock Awards $112,463, Option Awards $37,487, Total $224,950 |
| 2022-04-15 | Brian P. Concannon Age 64 Director since 2013 Committees: Compensation Strategy Biographical Information: Mr. Concannon served as President and CEO of Haemonetics Corporation, a publicly traded company (NYSE: HAE) from April 2009 to October 2015. He joined Haemonetics in 2003 and served in various roles to include the President, Global Markets in 2006 and the Chief Operating Officer in 2007-2009. In April 2009, Mr. Concannon was promoted to President and Chief Executive Officer, and elected to the Haemonetics board of directors. Prior to joining Haemonetics, Mr. Concannon was the President, Northeast Region, for Cardinal Health Medical Products and Services where he was employed since 1998. From 1985 to 1998, he was employed by American Hospital Supply Corporation, Baxter Healthcare Corp and Allegiance Healthcare in a series of sales and operations management positions of increasing responsibility. He has served in leadership roles within the healthcare industry for more than 30 years. Mr. Concannon was also a member of the board of directors of South Shore Health and was Vice-Chair from January 2017 through December 2019. Mr. Concannon has been a member of the board of directors of Hivers and Strivers, an investment fund, since September 2020, a member of the board of Aegle Health Partners since October 2021, Chair of the board of My Brothers Keeper since 2021 and a member of the board of directors of VetAccel since November 2019. Mr. Concannon was also appointed as the Civilian Aide to the Secretary of the Army for Massachusetts in October 2017. Mr. Concannon is a 1979 graduate of West Point. The Board of Directors has determined that Mr. Concannon is independent within the meaning of the rules of the New York Stock Exchange. |
| 2023-04-11 | Brian P. Concannon Age 65 Director since 2013 Committees: • Compensation (Chair) • Strategy Director Compensation Table Brian P. Concannon Fees Earned or Paid in Cash: $79,492 Stock Awards: $37,450 Option Awards: $137,498 Total: $254,440 |
| 2024-04-08 | Brian P. Concannon Age 66 Director since 2013 Committees: Compensation (Chair), Strategy. 2023 Non-Employee Director Compensation Table shows total $257,370. |
| 2025-04-08 | Mr. Concannon served as President and CEO of Haemonetics Corporation. The Board has determined that Mr. Concannon is independent. Committees: Compensation (Chair), Strategy. Total compensation for 2024 was $319,766. |
| Filing Date | Source Excerpt |
|---|---|
| 2014-06-13 | Brian Concannon, 56, is the President and Chief Executive Officer of the Company. He joined Haemonetics in 2003 as the President, Patient Division and was promoted to President, Global Markets in 2006. In 2007, Mr. Concannon was promoted to Chief Operating Officer and in April 2009, Mr. Concannon was promoted to President and Chief Executive Officer, and elected to the Haemonetics Board of Directors. |
| 2015-06-11 | Mr. Concannon, 57, is the President and Chief Executive Officer of the Company. |
Data sourced from SEC filings. Last updated: 2025-12-06